Table 6.
FNA results in individual patients.
| Pt no. | PanNET no. | CT/MRI before FNA | Size PanNET| (mm) | Year FNA | Time 1st positive imaging until FNA (years) | FNA result | Time FNA until resection (years) | Surgery outcome | Follow-up |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | Positive | 50 | 2001 | 0 | PanNET | 0.5 | PanNET WHO G2 | |
| 2 | 2 | Positive | 10.5 | 2004 | 2.3 | PanNET | PanNET | ||
| 3 | Positive | 5 | 2004 | 2.3 | PanNET | PanNET | |||
| 3 | 4 | Positive | 23 | 2009 | 8.3 | PanNET | PanNET | ||
| Positive | 20 | 2013 | 13 | PanNET | |||||
| 4 | 5 | Positive | 24 | 2009 | 1.5 | PanNET | 0.3 | PanNET WHO G1 | |
| 5 | 6 | Positive | 21 | 2012 | 7.8 | PanNET | PanNET | ||
| 6 | 7 | Positive | 40 | 1995 | 0 | Normal pancreas | PanNET | ||
| 7 | 8 | Positive | 8 | 2010 | 3.5 | PanNET | PanNET | ||
| 8 | 9 | Positive | 13 | 2009 | 4 | PanNET | PanNET | ||
| 9 | 10 | Positive | 22 | 2007 | 0.3 | Normal pancreas | PanNET | ||
| Positive | 22 | 2008 | 0.8 | PanNET | |||||
| 10 | 11 | Positive | 13 | 2007 | 0.3 | PanNET | PanNET | ||
| 11 | 12 | Negative | 13.7 | 2009 | NA* | PanNET | PanNET | ||
| 12 | 13 | Positive | 13 | 2005 | 0.3 | PanNET | 0 | PanNET WHO G1 | |
| 13 | 14 | Positive | 15 | 2016 | 17 | PanNET | PanNET | ||
| 14 | 15 | Positive | 160 | 2007 | 0 | PanNET | 0.5 | PanNET WHO G1 | |
| 15 | 16 | Positive | 54 | 2000 | 1 | PDAC | PDAC | ||
| Positive | 54 | 2001 | 1.3 | PDAC | |||||
| 16 | 17 | Positive | 60 | 1994 | 4.5 | PDAC | PanNET | ||
| 17 | 18 | Positive | 60 | 2000 | 0 | PanNET | PanNET | ||
| 18 | 19 | Positive | 14 | 2009 | 0 | Normal pancreas/not representative | PanNET | ||
| 19 | 20 | Negative | 15.1 | 2009 | NA* | PanNET | PanNET | ||
| 20 | 21 | Positive | 10 | 2010 | 0.3 | PanNET | 4.5 | PanNET WHO G1 | |
| 21 | 22 | Positive | 24.4 | 2007 | 0.3 | Cyst | 0.5 | PanNET WHO G1 | |
| 22 | 23 | Positive | 40 | 2016 | 7.5 | PDAC | 0 | PDAC | |
| 23 | 24 | Positive | 20 | 2004 | 9.8 | PanNET | PanNET | ||
| 24 | 25 | Negative | Unknown | 2004 | NA* | Normal pancreas | 8.8 | PanNET WHO G1 | |
| 25 | 26 | Positive | 25 | 2014 | 4.5 | PanNET | 0.9 | PanNET WHO G2 | |
| 26 | 27 | Positive | Unknown | 2013 | 0.5 | Not representative | PanNET | ||
| 27 | 28 | Positive | 10 | 2011 | 0 | PDAC | 0.3 | PanNET WHO G1 | |
| 28 | 29 | Positive | 60 | 2013 | 0 | PanNET | PanNET | ||
| 29 | 30 | Positive | 21 | 2017 | 3.3 | PanNET | 0.2 | PanNET WHO G1 | |
| 30 | 31 | Positive | 8 | 2016 | 0.8 | PanNET | 0 | PanNET WHO G1 | |
| 31 | 32 | Positive | 7 | 2016 | 0.3 | PanNET | 0 | PanNET WHO G1 | |
| 32 | 33 | Negative | 6 | 2017 | NA* | PanNET | PanNET | ||
| 33 | 34 | Negative | 10 | 2015 | NA* | Cyst | PanNET |
*EUS first positive imaging study.
|Based on CT, MRI, or EUS.
CT, computed tomography; EUS, endoscopic ultrasonography; FNA, fine needle aspiration; MRI, magnetic resonance imaging; NA, not applicable; PanNET, pancreatic neuroendocrine tumor; PDAC, pancreatic ductal adenocarcinoma.